Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines

    loading  Checking for direct PDF access through Ovid

Abstract

Current drug discovery strategies include both molecular and empirical approaches. The molecular approaches are predominantly hypothesis-driven and are referred to as target-based. The empirical approaches are referred to as phenotypic because they rely on phenotypic measures of response. A recent analysis revealed the phenotypic approaches to be the more successful strategy for small-molecule, first-in-class medicines. The rationalization for this success was the unbiased identification of the molecular mechanism of action (MMOA).

Related Topics

    loading  Loading Related Articles